Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-11

Clinical Trial Update: Colon Cancer Liquid Biopsy Investigation of Methylation-based Biomarkers Evaluation Using Delta-HLD (CLIMBED)

View source ↗

Summary

A clinical trial update announcing recruitment for a study evaluating methylation-based biomarkers in colorectal cancer using a Delta-HLD liquid biopsy approach…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Epiliquid Holding, Inc | Conditions: Colorectal Cancer (CRC) | Status: RECRUITING